Ready-to-use therapeutic food (RUTF) has achieved a remarkable milestone: saving an estimated 7 million children’s lives over three decades. This nutrient-dense paste, containing peanuts, milk powder, oil, and essential vitamins, revolutionized treatment for severe acute malnutrition by enabling home-based care in resource-limited settings.
Yet this success story carries an urgent caveat. According to UNICEF’s 2024 analysis, 45 million children under five currently require RUTF treatment, but only 5 million receive it—representing an 89% treatment gap. Supply chain disruptions, limited healthcare infrastructure, and concentrated crises in sub-Saharan Africa and South Asia continue to prevent millions of vulnerable children from accessing this life-saving intervention.
The treatment disparity underscores a critical challenge in global health equity: proven solutions exist, but delivering them to the world’s most vulnerable populations remains a pressing priority.
Was this article helpful?
